SCHEMBL6677754

SCHEMBL6677754

C[C@H](Cc1ccc(S(=O)(=O)c2ccc(O)c(C(=O)O)c2)cc1)NC(=O)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTPN1 P18031 1/20 0.40
CASP3 P42574 4/20 0.39
CASP1 P29466 1/20 0.39
CASP2 P42575 1/20 0.39
CASP4 P49662 1/20 0.39
CASP5 P51878 1/20 0.39
CASP7 P55210 1/20 0.39
CASP6 P55212 1/20 0.39
CASP8 Q14790 1/20 0.39
ESR1 P03372 1/20 0.38
KCNH2 Q12809 1/20 0.38
KLKB1 P03952 1/20 0.38
CTSB P07858 1/20 0.38
MMP9 P14780 1/20 0.38
DNMT1 P26358 1/20 0.38
DNMT3B Q9UBC3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6800681 1.00 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10PTPN1
SCHEMBL6805794 0.89 MAPT (0.42) ALDH1A1KDM4EESR1KCNH2MEN1
SCHEMBL6540853 0.87 ESR1 (0.42) ALDH1A1ESR1KCNH2POLBCNR1
SCHEMBL6540415 0.87 CNR1 (0.40) ALDH1A1ESR1KCNH2CNR1GAA
SCHEMBL6680778 0.86 CNR1 (0.40) ALDH1A1HSD17B10CASP3ESR1KCNH2
SCHEMBL6805798 0.86 ESR1 (0.39) ESR1KCNH2MEN1KMT2APOLB
SCHEMBL6805802 0.86 ESR1 (0.39) ESR1KCNH2MEN1KMT2APOLB
SCHEMBL6540648 0.86 ABCB11 (0.41) ESR1KCNH2CNR1GAAACACB
SCHEMBL6810020 0.86 ABCB11 (0.41) ESR1KCNH2CNR1GAAACACB
SCHEMBL6677082 0.84 ACACB (0.50) ESR1KCNH2MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 ALDH1A1 168/4885KDM4E 994/4885HPGD 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.